Benutzerspezifische Werkzeuge
Sie sind hier: Startseite Sonderforschungsbereich 655 Publikationen B2-Bornhäuser / Werner

B2: SFB-relevante Publikationen

  • Stoelzel F, Hackmann K, Kuithan F, Mohr B, Fuessel M, Oelschlaegel U, Thiede C, Roellig C, Platzbecker U, Schetelig J, Illmer T, Schaich M, Seliger B, Hartmann A, Baretton G, Zietz C, Ehninger G, Schroeck E, and Bornhäuser M (2012): Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation 7, 744-9.

  • Kurth I, Franke K, Pompe T, Bornhäuser M, Werner C  (2011): Extracellular matrix functionalized microcavities to control hematopoietic progenitor cell fate. Macromolecular Bioscience 11, 739-47.
    Niehage C, Steenblock C, Pursche T, Bornhäuser M, Corbeil D, Hoflack B (2011): The cell surface proteome of human mesenchymal stromal cells. PLoS One; 6(5):e20399. Epub 2011 May 26.

  • Sobkow L, Seib FP, Prodanov L,  Kurth I, Drichel J, Bornhäuser M, Werner C (2010): Prolonged transendothelial migration of human haematopoietic stem and progenitor cells (HSPCs) towards hydrogel-released SDF-1. Annals of Hematology 90, 865-871.

  • Seib FP, Lanfer B, Bornhäuser M, Werner C  (2010): Biological activity of extracellular matrix-associated BMP-2. Journal of Tissue Engineering and Regenerative Medicine 4, 324-327.

  • Stiehler M, Seib FP, Rauh J, Goedecke A, Werner C , Bornhäuser M, Gunther KP, Bernstein P (2010): Cancellous bone allograft seeded with human mesenchymal stromal cells: a potential good manufacturing practice-grade tool for the regeneration of bone defects. Cytotherapy 12, 658-668.

  • Freund D, Fonseca AV, Janich P, Bornhäuser M, Corbeil D (2010): Differential expression of biofunctional GM1 and GM3 gangliosides within the plastic-adherent multipotent mesenchymal stromal cell population. Cytotherapy. 12, 131-142.

  • Jing D, Fonseca AV, Alakel N, Fierro FA, Muller K, Bornhäuser M, Ehninger G, Corbeil D, Ordemann R (2010): Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro. Haematologica 95, 542-550.

  • Jing D, Oelschlaegel U, Ordemann R, Holig K, Ehninger G, Reichmann H, Ziemssen T, Bornhäuser M (2010): CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function. Bone Marrow Transplant. 45, 1489-96.

  • Jacobi A, Thieme S, Lehmann R, Ugarte F, Malech HL, Koch S, Thiede C, Muller K, Bornhäuser M, Ryser M, Brenner S (2010): Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. Exp. Hematol. 38, 180-190.

  • Kurth I, Franke K, Pompe T, Bornhäuser M, Werner C  (2009): Hemapoietic stem and progenitor cells in adhesive microcavities. Integrative Biology 1, 427-434

  • Seib FP, Franke M, Jing D, Werner C, Bornhäuser M (2009): Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol. 88, 257-71.

  • Seib FP, Müller K, Franke M, Grimmer M, Bornhäuser M, Werner C  (2009): Engineered extracellular matrices modulate the expression profile and feeder properties of bone marrow-derived human multipotent mesenchymal stromal cells. Tissue Engineering: Part A, 15, 3161-3171.

  • Seib FP, Prewitz M, Werner C, Bornhäuser M (2009):
    Matrix elasticity regulates cytokine expression of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). Biochemical and Biophysical Research Communications 389, 663-667.

  • Fierro FA, Taubenberger A, Puech PH, Ehninger G, Bornhäuser M, Muller DJ, Illmer T (2008): BCR/ABL expression of myeloid progenitors increases beta1-integrin mediated adhesion to stromal cells. J. Mol. Biol. 377, 1082-1093.

  • Ryser MF, Ugarte F, Thieme S, Bornhäuser M, Roesen-Wolff A, Brenner S (2008): mRNA Transfection of CXCR4-GFP Fusion-Simply Generated by PCR-Results in Efficient Migration of Primary Human Mesenchymal Stem Cells. Tissue Eng Part C. Methods 14, 179-184.

  • Alberti K, Davey RE, Kento O, George S, Salchert K, Seib FP, Pompe T, Bornhäuser M, Nagy A, Werner C, Zandstra P (2008): Functional immobilisation of signalling proteins enables control of stem cell fate. Nature Methods, 5, 645-50.

  • von Bonin M, Stolzel F, Goedecke A, Richter A, Wuschek N, Holig K, Platzbecker U, Illmer T, Schaich M, Kiani A, Schetelig J, Ordemann R, Ehninger G, Schmitz M, Bornhäuser M (2008): Treatment of refractory acute GVHD with third party MSC expanded in platelet lysate containing medium. Bone Marrow Transplant 3, 245-51.

  • Stamov D, Grimmer M, Salchert K, Pompe T, Werner C (2008): Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology. Biomaterials 29, 1-14.
    Lanfer B; Freudenberg U, Zimmermann R, Stamov D, Körber V, Werner C (2008): Aligned fibrillar collagen matrices obtained by shear flow deposition. Biomaterials 29, 3888-3895.

  • Franke K, Pompe T, Bornhäuser M, Werner C (2007): Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells. Biomaterials 28, 836-843.

  • Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, Bornhäuser M (2007): Inhibition of platelet-derived growth factor receptor-ß by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif., 40, 355-366.

  • Bauer N, Fonseca AV, Florek M, Freund D, Jászai J, Bornhäuser M, Fargeas CA, Corbeil D (2007) New insights into the cell biology of hematopoietic progenitors by studying Prominin-1 (CD133) Cells Tissues Organs 188, 127-138.

  • Oswald J, Steudel C, Salchert K, Joergensen B, Thiede C, Ehninger G, Werner C, Bornhäuser M (2006): Gene expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells 24, 494-500.

  • Freund D, Bauer N, Boxberger S, Feldmann S, Streller U, Ehninger G, Werner C, Bornhäuser M, Oswald J, Corbeil D (2006) Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev., 15, 815-829.


« Januar 2020 »

Funding program: